PHAR (Pharming Group) Dividends per Share: $0.00 (TTM As of Mar. 2026)

What is Pharming Group Dividends per Share?

Pharming Group PHAR -0.25% 76 Dividends per Share is $0.00 as of Mar. 2026. GuruFocus rates PHAR with a GF Score™ of 76/100 and a GF Value™ of $14.23 (Fairly Valued). The stock has 1 warning sign investors should review.

Pharming Group's dividends per share for the three months ended in Mar. 2026 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Pharming Group's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Pharming Group (NAS:PHAR) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Pharming Group's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	0	/	-0.07
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharming Group Dividends per Share Related Terms

Pharming Group Dividends per Share Historical Data

* Premium members only.

The historical data trend for Pharming Group's Dividends per Share can be seen below:

Pharming Group Dividends per Share Chart

Pharming Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividends per Share

Get a 7-Day Free Trial

0.00

Pharming Group Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividends per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PHAR vs VRTX, REGN, ALNY: Dividends per Share Comparison

For the Biotechnology subindustry, Pharming Group's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharming Group Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Pharming Group's Dividend Yield % falls into.

Save Embed

76GF Score

Pharming Group PHAR

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Pharming Group Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of $0.00 mean?

Pharming Group (PHAR) has a Dividends per Share of $0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Pharming Group and its competitors.

Is Pharming Group's Dividends per Share too high?

Pharming Group's current Dividends per Share is $0.00. Overall, Pharming Group has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Pharming Group's Dividends per Share compare to VRTX and REGN?

Pharming Group's Dividends per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Biotechnology company?

A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Pharming Group and its competitors. Pharming Group's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Pharming Group stock overvalued right now?

Based on GuruFocus' analysis, Pharming Group (PHAR) is currently considered Fairly Valued. The stock's GF Value™ is $14.23, compared to a current price of $14.18 — trading 0.4% below its estimated fair value. The current Dividends per Share is $0.00. Pharming Group's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For Pharming Group (PHAR), the current Dividends per Share is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharming Group (PHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Pharming Group stock appears to be undervalued. The current stock price of $14.18 is trading 0.4% below its estimated GF Value™ of $14.23. GuruFocus considers Pharming Group to be Fairly Valued.

Key valuation signals for PHAR:

Dividends per Share: $0.00
GF Value™: $14.23 vs. price of $14.18 (0.4% below fair value)
GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the PHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharming Group Business Description

Industry Healthcare Biotechnology

Comparable Companies XAMS:VVY XAMS:LKFT VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX INCY INSM HKSE:02269 ASND

Other Exchanges PHGUF:USA PHARM:Netherlands PHARMa:UK 0QCO:UK PHGN:Germany

Address Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website https://www.pharming.com

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

76GF Score

Get the complete analysis for PHAR

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.18

Price

$14.23

GF Value

View PHAR Analysis

See Dividends per Share data for all stocks →